The impact of fear of attacks on pain‐related disability in cluster headache: Insights from the fear avoidance model
Headache: The Journal of Head and Face Pain · 2025-01 · 65 (1) · 45-53
DOI: 10.1111/head.14823 ↗Kurz gefasst
Fachartikel in der Zeitschrift Headache: The Journal of Head and Face Pain, online erschienen am 03.09.2024. Verfasst von Janosch Fox und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, PFH Göttingen, Göttingen, Germany. Hauptthemen laut MEDLINE: Fear, Cluster Headache, Avoidance Learning, Models, Psychological. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universität Duisburg-Essen.
Abstract (Originalsprache)
Objective
This study utilized the theoretical framework of the “fear avoidance model” (FAM) and investigated the role of fear of attack in pain‐related disability. To this end, a measurement specific to cluster headache (CH) was used to investigate whether fear of attacks, alongside attack frequency, is a significant predictor of pain‐related disability in CH.
Background
Cluster headache substantially impacts daily functioning, yet empirical research exploring specific contributing factors is limited.
Methods
A cross‐sectional online survey was undertaken in patients with CH, gathering sociodemographic, clinical data, and responses on the Cluster Headache Scale and the Depression, Anxiety and Stress Scale.
Results
Analysis of data from 640 patients (chronic CH: 287/640 [44.8%]; female: 264/640 [41.3%]; male: 373/640 [58.3%]; gender diverse: three of 640 [0.5%]; age range: 18–86 years; mean [standard deviation] Cluster Headache Scales subscale disability score: 36.9 [9.8]; out of 869 respondents) revealed that both attack frequency and fear of attacks significantly predicted pain‐related disability ( p < 0.001, percentage of variance explained: R 2 = 0.24). More variance was explained by fear of attacks ( R 2 = 0.22) than by attack frequency ( R 2 = 0.02). This relationship remained significant even when controlling for depression and anxiety, which were also identified as independent predictors of pain‐related disability ( p < 0.001, R 2 = 0.44).
Conclusion
This study emphasizes the relevance of psychological factors in CH‐related disability. Fear of attacks was found to be an independent predictor, while attack frequency was of minor relevance. Empirical investigation of the FAM in CH could improve the understanding of the mechanisms underlying disability and contribute to the development of CH‐specific interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychology, PFH Göttingen, Göttingen, Germany.
- University Medical Centre Göttingen, Göttingen, Germany.
- Medical Faculty, University of Duisburg-Essen, Duisburg, Germany.
- Headache Center Frankfurt, Frankfurt am Main, Germany.
- Benedictus Hospital Feldafing, Feldafing, Germany.
ORCID-Profile: Charly Gaul
Förderung
- Universität Duisburg-Essen
Zitieren
APA
Fox, J., Gaul, C., Slijepcevic, M., Ohse, J., Peperkorn, N., & Shiban, Y. (2025). The impact of fear of attacks on pain‐related disability in cluster headache: Insights from the fear avoidance model. Headache: The Journal of Head and Face Pain, 65(1), 45-53. https://doi.org/10.1111/head.14823
Vancouver
Fox J, Gaul C, Slijepcevic M, Ohse J, Peperkorn N, Shiban Y. The impact of fear of attacks on pain‐related disability in cluster headache: Insights from the fear avoidance model. Headache: The Journal of Head and Face Pain. 2025;65(1):45-53. doi:10.1111/head.14823
BibTeX
@article{Fox2025,
author = {Fox, Janosch and Gaul, Charly and Slijepcevic, Mirjana and Ohse, Julia and Peperkorn, Nicolina and Shiban, Youssef},
title = {The impact of fear of attacks on pain‐related disability in cluster headache: Insights from the fear avoidance model},
journal = {Headache: The Journal of Head and Face Pain},
year = {2025},
volume = {65},
number = {1},
pages = {45--53},
doi = {10.1111/head.14823}
}
EUVIMED